A second case of acute liver failure (ALF) resulting in the death has been reported in a young recipient of Elevidys ...

French drug developer Averoa today announced that the European Commission (EC) has granted marketing authorization for ...

Swiss pharma giant Roche announced today its decision to proceed with Phase III development of prasinezumab, an ...

TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...

Boston, USA-based biotech Solu Therapeutics today announced the appointment of Enda Moran as chief operating officer (COO).

China’s National Medical Products Administration (NMPA) held a meeting last week to conduct the 2024 annual review of the ...

French pharma major Sanofi and US partner Regeneron Pharmaceuticals yesterday presented positive results from the EVEREST ...

Californian biotech Jasper Therapeutics presented data from the 180mg cohort of the company’s SPOTLIGHT Phase Ib/IIa study of ...

With exports valued at 105.5 billion Swiss francs ($130.2 billion) and a 38.5% share of total exports, the pharmaceutical ...

Initial results from the ALXN1210-TMA-314 Phase III trial showed that UK pharma major AstraZeneca’s Ultomiris (ravulizumab) ...

A clinical-stage biotech company based in Redwood City, California, developing tissue-restorative biologics for chronic ...

Formed in 2024 by ADQ, a sovereign wealth fund, Arcera consolidates several pharmaceutical businesses, including Acino ...